ES2136061T3 - Nucleosidos terapeuticos. - Google Patents

Nucleosidos terapeuticos.

Info

Publication number
ES2136061T3
ES2136061T3 ES90909151T ES90909151T ES2136061T3 ES 2136061 T3 ES2136061 T3 ES 2136061T3 ES 90909151 T ES90909151 T ES 90909151T ES 90909151 T ES90909151 T ES 90909151T ES 2136061 T3 ES2136061 T3 ES 2136061T3
Authority
ES
Spain
Prior art keywords
therapeutic nucleosides
nucleosides
therapeutic
prophylaxis
hiv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90909151T
Other languages
English (en)
Inventor
Susan Mary Daluge
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Application granted granted Critical
Publication of ES2136061T3 publication Critical patent/ES2136061T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

ESTA INVENCION DESCRIBE NUCLEOSIDOS CARBOCICLICOS PURINOS 6-SUSTITUIDOS Y SU USO EN TERAPIA MEDICA, PARTICULARMENTE EN EL TRATAMIENTO Y PROFILAXIS DE INFECCIONES DEL VIH Y VHB. TAMBIEN SE DESCRIBEN FORMULAS FARMACEUTICAS Y PROCESOS PARA LA PREPARACION DE COMPUESTO DE ACUERDO CON LA INVENCION.
ES90909151T 1989-06-27 1990-06-26 Nucleosidos terapeuticos. Expired - Lifetime ES2136061T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US37178989A 1989-06-27 1989-06-27

Publications (1)

Publication Number Publication Date
ES2136061T3 true ES2136061T3 (es) 1999-11-16

Family

ID=23465413

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90909151T Expired - Lifetime ES2136061T3 (es) 1989-06-27 1990-06-26 Nucleosidos terapeuticos.

Country Status (7)

Country Link
EP (1) EP0479822B1 (es)
JP (1) JP3164361B2 (es)
AT (1) ATE183508T1 (es)
DE (1) DE69033252T2 (es)
DK (1) DK0479822T3 (es)
ES (1) ES2136061T3 (es)
WO (1) WO1991000282A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9009861D0 (en) 1990-05-02 1990-06-27 Glaxo Group Ltd Chemical compounds
IL100502A (en) * 1991-01-03 1995-12-08 Iaf Biochem Int PHARMACEUTICAL PREPARATIONS CONTAINING CIS-4-AMINO-1-) 2-HYDROXIMETHIL-1,3-OXETYOLEN-5-IL (-
GB9110874D0 (en) * 1991-05-20 1991-07-10 Iaf Biochem Int Medicaments
US5233041A (en) * 1991-10-07 1993-08-03 Glaxo Group Limited Synthesis of a 3,4-dihydroxy-1-cyclopentanylpurinone from a 2,3-unsaturated-1-cyclopentanylpurinone
WO2007064795A2 (en) * 2005-11-30 2007-06-07 Inotek Pharmaceuticals Corporation Purine derivatives and methods of use thereof
CN107383010A (zh) * 2017-08-18 2017-11-24 上海现代制药海门有限公司 一种化合物及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1003815A4 (fr) * 1988-01-20 1992-06-23 Univ Minnesota Nucleosides dideoxydidehydrocarbocyliques et composition pharmaceutique les contenant.
GB8815265D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Therapeutic nucleosides

Also Published As

Publication number Publication date
DE69033252D1 (de) 1999-09-23
DK0479822T3 (da) 2000-03-20
EP0479822A1 (en) 1992-04-15
JP3164361B2 (ja) 2001-05-08
EP0479822B1 (en) 1999-08-18
JPH04506344A (ja) 1992-11-05
ATE183508T1 (de) 1999-09-15
WO1991000282A1 (en) 1991-01-10
DE69033252T2 (de) 1999-12-09

Similar Documents

Publication Publication Date Title
MY104043A (en) Therapeutic nucleosides.
MY104575A (en) Therapeutic nucleosides.
ATE108794T1 (de) Therapeutische nucleoside und deren herstellung.
UA29429C2 (uk) Фармацевтична композиція для лікування вірусних інфекцій, спосіб отримання композиції, спосіб лікування або профілактики віл-інфекції у людини
HK1000142A1 (en) Antiviral pyrimidine and purine compounds process for their preparation and pharmaceutical compositions containing them
FI904445A0 (fi) Antivirala foereningar.
MY117892A (en) Therapeutic compounds
DE3875769D1 (de) Therapeutische nukleoside.
MY105855A (en) Therapeutic nucleotides.
DK0479822T3 (da) Terapeutiske nucleosider
DK347289A (da) Terapeutiske forbindelser
MY106295A (en) Anti-infective nucleosides
MX9303985A (es) Nucleosidos terapeuticos.
ES2063147T3 (es) Compuestos antivirales.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 479822

Country of ref document: ES